Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who agree to take part in the eligibility screening for the related study (Protocol 20210081) will have their tumour tissue tested for a specific gene change called KRAS G12C as part of this performance study.
Who may not be able to join:
- No separate exclusion criteria have been listed for this performance study — the trial site would be the appropriate contact for clarification on eligibility.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sarah Johnson, Dr., Qiagen Manchester Limited
Phone: 0044 07825866041
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of KRAS G12C mutation status; Progression Free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.